[ET Net News Agency, 4 September 2025]  ALI HEALTH (00241) rose 5.2% to HK$6.72.
  It hits an intra-day high of HK$6.73, hitting a 52-week high, and an intra-day low of 
HK$6.39. The total shares traded was 152.64 million, with a value of HK$1.01b. The active 
buy/sell ratio is 57:43, with net buying turnover of HK$141.15m. MERRILL LYNCH FE accounts
for greatest net responsive buying turnover of HK$26.42m, with volume weighted average  
price of HK$6.58. CHINA INV INFO accounts for greatest net responsive selling turnover of 
HK$42.75m, with volume weighted average price of HK$6.606. The stock has risen a combined 
24.9% over the past 5 consecutive trading days. 
  The Hang Seng Index now fell 99 points, or 0.4% to 25,243; the Hang Seng TECH Index now 
fell 29 points, or 0.5% to 5,654. 
  
          Basic Information 
          ================= 
  
  ----------------------------------
  Nominal     6.720 % Chg    +5.16% 
  High        6.730 Low       6.390 
  Shares Tr 152.64m Turnover  1.01b 
  10-D SMA    5.824 %H.V     47.581 
  20-D SMA    5.516 VWAP      6.590 
  50-D SMA    5.004 RSI14    80.659 
  ----------------------------------
Status: Hitting a 52-week high, active buy/sell ratio is 57:43, with net buying turnover  
of HK$141.15m, rising a combined 24.9% over the past 5 consecutive trading days 
  
Performance of stocks in the same sector or of relevance
========================================================
  
  Stock (Code)          Price (HK$) Change (%)
  --------------------------------------------- 
  ALI HEALTH (00241)           6.72      +5.16
  DAMAI ENT (01060)            1.11      -0.89
  ZTO EXPRESS-W (02057)      143.30      +1.70
  ROBOSENSE (02498)           37.14      -1.22
  SYNAGISTICS (02562)         17.08      +6.68
  CICC (03908)                20.12      -0.40
  SF INTRA-CITY (09699)       14.70      -2.33
  XPENG-W (09868)             77.30      -2.09
  HUITONGDA NET (09878)       15.16      +3.34
  NETEASE MUSIC (09899)      270.40      +2.97
  --------------------------------------------- 
  (ed)



 
 